Drug allergy diagnosis

Immunology and Allergy Clinics of North America

Volumn 34, Issue 3, 2014, Pages 461-471

  Chiriac, Anca M ^a   Demoly, Pascal ^a,b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Drug allergy work up; Drug hypersensitivity reaction; Imputability; Natural history; Severity signs

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; GADOLINIUM; HEPARIN DERIVATIVE; IMMUNOGLOBULIN E ANTIBODY; IODINATED CONTRAST MEDIUM; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLATINUM COMPLEX; RITUXIMAB;

AGE; ANTIBODY BLOOD LEVEL; ASPIRIN EXACERBATED CUTANEOUS DISEASE; CHRONIC RHINOSINUSITIS; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; DESENSITIZATION; DISEASE SEVERITY; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG REEXPOSURE; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; HUMAN; INTRACUTANEOUS TEST; MEDICAL HISTORY; PHYSICAL EXAMINATION; PRICK TEST; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; REVIEW; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; COMORBIDITY; DISEASE MANAGEMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SKIN TEST;

COMORBIDITY; DESENSITIZATION, IMMUNOLOGIC; DISEASE MANAGEMENT; DRUG HYPERSENSITIVITY; HUMANS; PHARMACOVIGILANCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN TESTS;

EID: 84904106012     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2014.03.002     Document Type: Review

References (43)

1. Demoly P., Adkinson N.F., Brockow K., et al. International consensus on drug allergy. Allergy 2014, 69:420-437.
2. Limsuwan T., Demoly P. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock). Med Clin North Am 2010, 94(4):691-710.
3. Scherer K., Bircher A.J. Danger signs in drug hypersensitivity. Med Clin North Am 2010, 94(4):681-689.
4. Kardaun S.H., Sidoroff A., Valeyrie-Allanore L., et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 2007, 156(3):609-611.
5. Mertes P.M., Malinovsky J.M., Jouffroy L., et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. JInvestig Allergol Clin Immunol 2011, 21(6):442-453.
6. Chiriac AM, Demoly P. Positive predictive value of skin testing with β-lactams. Abstract P17:45-6. Programme of the 5th Drug Hypersensitivity Meeting, Munich 2012. Available at:. Accessed April 27, 2014. http://www.eaaci.org/images/files/Abstract_Books/2012/DHM2012.pdf.
7. Blanca M., Torres M.J., Garcia J.J., et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. JAllergy Clin Immunol 1999, 103(5 Pt 1):918-924.
8. Vultaggio A., Matucci A., Nencini F., et al. Drug-specific Th2 cells and IgE antibodies in a patient with anaphylaxis to rituximab. Int Arch Allergy Immunol 2012, 159(3):321-326.
9. Matucci A., Pratesi S., Petroni G., et al. Allergological invitro and invivo evaluation of patients with hypersensitivity reactions to infliximab. Clin Exp Allergy 2013, 43(6):659-664.
10. Guttormsen A.B., Johansson S.G., Oman H., et al. No consumption of IgE antibody in serum during allergic drug anaphylaxis. Allergy 2007, 62(11):1326-1330.
11. Barbaud A., Collet E., Milpied B., et al. Amulticentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 2013, 168(3):555-562.
12. Cernadas J.R., Brockow K., Romano A., et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010, 65(11):1357-1366.
13. Brennan P.J., Rodriguez Bouza T., Hsu F.I., et al. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment. JAllergy Clin Immunol 2009, 124(6):1259-1266.
14. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. JAllergy Clin Immunol 2003, 111(5):1095-1098.
15. Kowalski M.L., Makowska J.S., Blanca M., et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy 2011, 66(7):818-829.
16. Setkowicz M., Mastalerz L., Podolec-Rubis M., et al. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. JAllergy Clin Immunol 2009, 123(1):174-178.
17. Rubio M., Bousquet P.J., Gomes E., et al. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy 2012, 42(1):123-130.
18. Chiriac A.M., Demoly P. Multiple drug hypersensitivity syndrome. Curr Opin Allergy Clin Immunol 2013, 13(4):323-329.
19. Gex-Collet C., Helbling A., Pichler W.J. Multiple drug hypersensitivity-proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests. JInvestig Allergol Clin Immunol 2005, 15(4):293-296.
20. Gaig P., Garcia-Ortega P., Baltasar M., et al. Drug neosensitization during anticonvulsant hypersensitivity syndrome. JInvestig Allergol Clin Immunol 2006, 16(5):321-326.
21. Kanny G., Pichler W., Morisset M., et al. Tcell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests. JAllergy Clin Immunol 2005, 115(1):179-185.
22. Castells M.C., Tennant N.M., Sloane D.E., et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. JAllergy Clin Immunol 2008, 122(3):574-580.
23. Mallal S., Phillips E., Carosi G., et al. HLA-B*5701 screening for hypersensitivity to abacavir. NEngl J Med 2008, 358(6):568-579.
24. Chen P., Lin J.J., Lu C.S., et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. NEngl J Med 2011, 364(12):1126-1133.
25. Demoly P., Kropf R., Bircher A., et al. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy 1999, 54(9):999-1003.
26. Benahmed S., Picot M.C., Dumas F., et al. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med 2005, 165(13):1500-1505.
27. Sassolas B., Haddad C., Mockenhaupt M., et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 2010, 88(1):60-68.
28. Brockow K., Garvey L.H., Aberer W., et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013, 68(6):702-712.
29. Torres M.J., Gomez F., Dona I., et al. Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media. Allergy 2012, 67(7):929-935.
30. Caimmi S., Benyahia B., Suau D., et al. Clinical value of negative skin tests to iodinated contrast media. Clin Exp Allergy 2010, 40(5):805-810.
31. Chiriac A.M., Audurier Y., Bousquet P.J., et al. Clinical value of negative skin tests to gadolinium contrast agents. Allergy 2011, 66(11):1504-1506.
32. Ramirez L.F., Pereira A., Chiriac A.M., et al. Negative predictive value of skin tests to neuromuscular blocking agents. Allergy 2012, 67(3):439-441.
33. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, et al. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 2010, 105:259-273.
34. Brockow K., Romano A., Aberer W., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 2009, 64(2):234-241.
35. Ebo D.G., Leysen J., Mayorga C., et al. The invitro diagnosis of drug allergy: status and perspectives. Allergy 2011, 66(10):1275-1286.
36. Hjortlund J., Mortz C.G., Skov P.S., et al. One-week oral challenge with penicillin in diagnosis of penicillin allergy. Acta Derm Venereol 2012, 92(3):307-312.
37. Caubet J.C., Kaiser L., Lemaitre B., et al. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. JAllergy Clin Immunol 2011, 127(1):218-222.
38. Ponvert C., Perrin Y., Bados-Albiero A., et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011, 22(4):411-418.
39. Gomes E.R., Kvedariene V., Demoly P., et al. Patients' satisfaction with diagnostic drug provocation tests and perception of its usefulness. Int Arch Allergy Immunol 2011, 156(3):333-338.
40. Ponvert C. Diagnosis of allergic and non-allergic hypersensitivity reactions to commonly used drugs and biological substances in children: diagnostic algorithm. Arch Pediatr 2011, 18(4):486-492. [in French].
41. Demoly P., Romano A., Botelho C., et al. Determining the negative predictive value of provocation tests with beta-lactams. Allergy 2010, 65(3):327-332.
42. Defrance C., Bousquet P.J., Demoly P. Evaluating the negative predictive value of provocation tests with nonsteroidal anti-inflammatory drugs. Allergy 2011, 66(11):1410-1414.
43. Papadopoulos N.G., Agache I., Bavbek S., et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy 2012, 2(1):21.